Haemonetics Corporation operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Haemonetics with three other
companies in this sector in UNITED STATES :
sales of $382.93 million
of which 56%
of which 96%
was Impella product revenue), and
Cantel Medical Corp.
of which 46%
Haemonetics reported sales of $988.48 million
March of 2020.
increase of 2.2%
versus 2019, when the company's sales were $967.58 million.
This was the third consecutive year of growth at Haemonetics.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Haemonetics had sales
of $910.37 million.